cancer sequencing NorthShore, Sema4 Partnership Aims to Demonstrate Utility of Genomics for Personalized Care Premium NorthShore University HealthSystem is looking to normalize the use of genomics in patient care, particularly among medically underserved populations. Illumina Parries FTC Challenge to Grail Acquisition With Deals for Competing Customers Premium The US Federal Trade Commission's recent challenge raises the question who Illumina can acquire while remaining a quasi-monopolist for sequencing equipment. Illumina, Geneseeq Technology to Collaborate on IVD Cancer Testing Kits in China The deal to create a comprehensive genomic profiling test for Illumina's NextSeq 550Dx comes months after the instrument received regulatory approval in China. Nonprofit Count Me In to Return Genomic Results to Patients With Rare Cancers Premium With a new $16 million NCI grant, Count Me In is working with the Broad and Dana-Farber to engage osteosarcoma and leiomyosarcoma patients in their own care and in research. Natera Revenues Grow 35 Percent in Q4 The company reported $112.4 million in revenues compared to $83.2 million in Q4 2019, beating the average Wall Street estimate of $106.6 million. Feb 25, 2021 NantHealth Q4 Revenues Flat From Year Ago Feb 17, 2021 Exact Sciences Sketches Out Strategy for End-to-End Cancer Testing With Ashion Acquisition Premium Feb 9, 2021 UK Startup Gabriel Precision Oncology Leans on Congenica to Broaden NGS Use in Cancer Testing Premium Feb 2, 2021 Congenica, Gabriel Precision Oncology Partner on Clinical Interpretation for Somatic Cancer Testing Jan 13, 2021 At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing Jan 11, 2021 Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan Jan 6, 2021 TwinStrand Biosciences Explores Error Reduction Sequencing Tech in Various Applications Premium Dec 1, 2020 Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting Nov 24, 2020 Clinicians Face New Intervention Questions as Clonal Hematopoiesis Mutation Data Evolves Premium Nov 5, 2020 NantHealth Q3 Revenues Tick Up Slightly Oct 14, 2020 PierianDx, Pillar Biosciences Partner to Streamline NGS Cancer Analysis Sep 21, 2020 Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider Premium Sep 21, 2020 JP Morgan Downgrades Illumina to Neutral on Grail Deal Sep 16, 2020 Illumina's Stock Falls 9 Percent on Grail Acquisition Rumors Sep 16, 2020 LabCorp's Covance Joins Tempus TIME Trial Program Sep 11, 2020 Natera Prices $250M Public Stock Offering Aug 6, 2020 NantHealth Q2 Revenues Decline 12 Percent Aug 6, 2020 Illumina Q2 Revenues Drop 25 Percent Aug 6, 2020 Adaptive Biotechnologies Receives Expanded FDA Clearance for ClonoSeq MRD Assay Jul 29, 2020 Sema4 Raises $121M in Series C Financing Round Load More Breaking News Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.